Pakistan DRAP registration MDIR-0002746

Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m

Name: Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m — DRAP registration MDIR-0002746
Creator: Schazoo SPL Consumer Healthcare
Keywords: Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m, MDIR-0002746, Risk Class D, Schazoo SPL Consumer Healthcare, DRAP registration

PakistanRisk Class DSchazoo SPL Consumer Healthcare

VerifiedDRAP · official registry

Registration details

Registration Number: MDIR-0002746
Registration Date: 8/11/2021
Expiry Date: 8/10/2026
Action: ADD

Manufacturer

Name: Schazoo SPL Consumer Healthcare
Site: 71-B/C2, Gulberg-III, Lahore

About this record

Access Pakistan DRAP registration details for Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m. Registered as MDIR-0002746 on 8/11/2021. Expires on 8/10/2026. Manufacturer: Schazoo SPL Consumer Healthcare at 71-B/C2, Gulberg-III, Lahore.